Show sidebar
Show 9 12 18 24
Compare
Quick view
Add to wishlist

Buy Perjeta (Pertuzumab)

€1,470.00
Add to cart
Perjeta (pertuzumab) is a drug used to treat HER2-positive breast cancer in patients with metastatic cancer or as neoadjuvant treatment for patients with locally advanced, inflammatory or early breast cancer as part of a comprehensive early breast cancer treatment regimen.

What is Perjeta (pertuzumab) for?

Perjeta (pertuzumab) is indicated for the treatment of HER2-positive breast cancer in patients with metastatic cancer or as neoadjuvant treatment for patients with locally advanced, inflammatory or early breast cancer as part of a complete early breast cancer treatment regimen.